Our Scientific Expertise is Second to None
LifebankUSA®: Technological Leaders Caring for Your Future

As the only company that that offers cord blood, placenta blood and tissue banking-and the first to release placenta-derived stem cells for a successful transplant- we are proud to be technological leaders in a field that is helping so many families and is poised to help countless others.

We enable you to bank more of the stem cells (called CD34+ stem cells) shown to increase transplant success and survival,¹ and more mesenchymal*-like cells, which may prove to be useful in the emerging field of regenerative medicine.^2-5 Our strict procedures deliver unsurpassed purity,^{✝ 6}(see below) and you can trust that the stem cells your family banks will be available when you need them most. And you can be secure in the knowledge that our parent company, Celgene Corporation, provides the resources we need to keep doing what we do best: preserving stem cells for generations to come.

A Commitment to Purity

While all cord blood contains red blood cells, these cells have no therapeutic benefit and can actually lead to complications if not removed. LifebankUSA removes red blood cells through a process called "red blood cell depletion" to ensure that cord blood units are, on average, 99% pure.^{?, 6} Unlike LifebankUSA, some other cord blood banks have purity levels as low as 71%.^7,8 This means that their units contain more red blood cells that may cause complications if the cord blood units are used for treatment.

The LifebankUSA optimal red blood cell removal process eliminates the need for additional preparation at the time of transplant if your baby's stem cells are ever needed. This is important because further manipulation may lower the number of cells available for use.

*Mesenchymal is pronounced muh-ZINK-i-mul.
^✝Purity is defined as the absence of red blood cells.

"I feel strongly that LifebankUSA is a very reliable source of banking and collection. I know the people running it. I have experience with them..Actually, I recommend it to my friends."

Lolie Yu, MD
Pediatric Transplant Specialist
Children's Hospital of Louisiana State University Health Sciences Center
New Orleans

Dr. Lolie Yu has performed close to 500 stem cell transplants since 1990. She is a Professor of Pediatrics and the Division Chief of the Pediatric Hematology-Oncology program as well as the Director of the Bone Marrow Transplant program at the Louisiana State University Health Sciences Center/Children's Hospital in New Orleans, LA.

Please click here for more opinions from leading transplant surgeons and obstetricians.

Stem cells from placental and cord blood are indicated to rebuild blood. View Product Information